Abstract
Sclerosteosis and Van Buchem disease are related recessive sclerosing bone dysplasias caused by alterations in the SOST gene. We tested the hypothesis that craniodiaphyseal dysplasia (CDD) (MIM 122860), an extremely rare sclerosing bone dysplasia resulting facial distortion referred to as “leontiasis ossea”, could also be caused by SOST mutations. We discovered mutations c.61G>A (Val21Met) and c.61G>T (Val21Leu) two children with CDD. As these mutations are located in the secretion signal of the SOST gene, we tested their effect on secretion by transfecting the mutant constructs into 293E cells. Intriguingly, these mutations greatly reduced the secretion of SOST. We conclude that CDD, the most severe form of sclerotic bone disease, is part of a spectrum of disease caused by mutations in SOST. Unlike the other SOST-related conditions, sclerosteosis and Van Buchem disease that are inherited as recessive traits seem to be caused by a dominant negative mechanism.
Similar content being viewed by others
References
Appleby JN, Bingham RM (1996) Craniodiaphyseal dysplasia; another cause of difficult intubation. Paediatr Anaesth 6:225–229
Balemans W, Van Den Ende J, Freire Paes-Alves A, Dikkers FG, Willems PJ, Vanhoenacker F, de Almeida-Melo N, Alves CF, Stratakis CA, Hill SC, Van Hul W (1999) Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12–q21. Am J Hum Genet 64:1661–1669
Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537–543
Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van Hul W (2002) Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91–97
Beighton P, Barnard A, Hamersma H, van der Wouden A (1984) The syndromic status of sclerosteosis and van Buchem disease. Clin Genet 25:175–181
Bieganski T, Baranska D, Miastkowska I, Kobielski A, Gorska-Chrzastek M, Kozlowski K (2007) A boy with severe craniodiaphyseal dysplasia and apparently normal mother. Am J Med Genet A 143A:2435–2443
Botha MC, Beighton P (1983) Inherited disorders in the Afrikaner population of southern Africa. Part II. Skeletal, dermal and haematological conditions; the Afrikaners of Gamkaskloof; demographic considerations. S Afr Med J 64:664–667
Brueton LA, Winter RM (1990) Craniodiaphyseal dysplasia. J Med Genet 27:701–706
Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577–589
Gorlin RJ, Spranger J, Koszalka MF (1969) Genetic craniotubular bone dysplasias and hyperostosis: a critical analysis. Birth Defects 5:79–95
Halliday J (1949) A rare case of bone dystrophy. Br J Surg 37:52–63
Hamersma H, Gardner J, Beighton P (2003) The natural history of sclerosteosis. Clin Genet 63:192–197
Itagaki Y, Sakamoto M, Nishitani H (1989) A case of craniodiaphyseal dysplasia. No To Hattatsu 21:69–73
Kaitila I, Stewart RE, Landow E, Lachman R, Rimoin DL (1975) Craniodiaphyseal dysplasia. Birth Defects Orig Artic Ser 11:359–362
Kim CA, Honjo R, Bertola D, Albano L, Oliveira L, Jales S, Siqueira J, Castilho A, Balemans W, Piters E, Jennes K, Van Hul W (2008) A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin. Genet Test 12:475–479
Loots GG, Kneissel M, Keller H, Baptist M, Chang J, Collette NM, Ovcharenko D, Plajzer-Frick I, Rubin EM (2005) Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res 15:928–935
Macpherson RI (1974) Craniodiaphyseal dysplasia, a disease or group of diseases? J Can Assoc Radiol 25:22–33
Marden FA, Wippold FJ 2nd (2004) MR imaging features of craniodiaphyseal dysplasia. Pediatr Radiol 34:167–170
Naique S, Laheri VJ (2001) Stenosis of the cervical canal in craniodiaphyseal dysplasia. J Bone Joint Surg Br 83:328–331
Schaefer B, Stein S, Oshman D, Rennert O, Thurnau G, Wall J, Bodensteiner J, Brown O (1986) Dominantly inherited craniodiaphyseal dysplasia: a new craniotubular dysplasia. Clin Genet 30:381–391
Shivanand G, Kandpal H (2007) Craniodiaphyseal dysplasia: an unusual cause of recurrent dacryocystitis. Indian J Ophthalmol 55:219–221
Sutherland MK, Geoghegan JC, Yu C, Turcott E, Skonier JE, Winkler DG, Latham JA (2004) Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Bone 35:828–835
Uitterlinden AG, Arp PP, Paeper BW, Charmley P, Proll S, Rivadeneira F, Fang Y, van Meurs JB, Britschgi TB, Latham JA, Schatzman RC, Pols HA, Brunkow ME (2004) Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am J Hum Genet 75:1032–1045
Acknowledgments
This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080588) and the Samsung Biomedical Research Institute grant, SBRI C-A9-240-2.
Conflict of interest
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, S.J., Bieganski, T., Sohn, Y.B. et al. Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia. Hum Genet 129, 497–502 (2011). https://doi.org/10.1007/s00439-011-0947-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-011-0947-3